Alfred Health
Prostate, melanoma and rare cancer clinical trials will soon be available for patients in Gippsland thanks to a new partnership between Alfred Health and Latrobe Regional Hospital.
This year, the Victorian Melanoma Service (VMS) at The Alfred has seen a significant drop in referrals. But cases of melanoma have not dropped – prompting specialists to urge all Victorians to act now before it’s too late.
Between April and June this year, notifications of breast cancers decreased almost forty percent. Head of our breast surgery unit Dr Melanie Walker said, the COVID-19 restrictions should not be deterring people from seeing their GP for a breast examination if they have symptoms or concerns.
The Alfred has banded together with a private IVF company to save a patient's chance of having children after he was diagnosed with testicular cancer.
Alfred Cancer Trials (ACT) has begun testing two new Phase 1 cancer drugs, treating the first patients in the world on these trials.
Before COVID-19 struck, Natalia Rodriguez had been travelling from Launceston to The Alfred Oncology Unit every three weeks to take part in a clinical trial that could save her life.
Doctors at The Alfred were the only Australian researchers involved in an international randomised trial published in The Lancet that has shown patients live significantly longer when stereotactic ablative radiotherapy (SABR) is used to target all of their tumours.
Alfred Health Radiation Oncology experts have demonstrated the benefit of combining two forms of radiation treatment to target prostate cancer.
Australians will soon have greater access to potentially lifesaving treatments for rare cancers and other diseases with the establishment of a clinical trials network led by Alfred Health and Monash University.
A radiation therapy treatment that provides prostate cancer patients with an alternative to surgery is being acknowledged for 20 years of helping men at The Alfred.